# UCB Ventures

UCB Ventures is a Venture Capital based in Brussels, Belgium.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Brussels, Belgium
- **Region:** Europe
- **Address:** Brussels, Belgium
- **Founded:** 2017
- **Assets under management:** Undisclosed
- **Website:** ucbventures.com
- **LinkedIn:** https://www.linkedin.com/company/ucb-ventures

## Regulatory record

- **Reports private funds:** No

## About

UCB Ventures is UCB's venture arm focused on supporting medical companies. It has made 28 investments, including a Series B investment in SpliceBio on June 11, 2025. UCB Ventures has facilitated three portfolio exits, with Aetion exiting on May 15, 2025.

## Sectors

- Digital Health
- Biotechnology
- AI/ML
- Enterprise Software

## Questions

### Does UCB Ventures invest in therapeutics, digital health, or both?

UCB Ventures invests across both categories, provided the opportunity connects to the parent company's core immunology or neurology focus. Public portfolio evidence includes digital therapeutics, AI-powered drug discovery tools, and biomarker platforms. The firm does not invest in medical devices or health services unrelated to its therapeutic mandate.

### Where does UCB Ventures source its deal flow?

Deal flow originates through the parent company's academic and clinical research networks, direct relationships with biotech accelerators, and co-investor syndicates across Europe and North America. Key geographic hubs include the Boston-Cambridge cluster, the San Francisco Bay Area, and the EU's major life-sciences innovation centers.

## Related profiles

- [UBX Philippines](https://altss.com/profile/ubx-philippines)
- [UC Capital](https://altss.com/profile/uc-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/ucb-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology